Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07343466

Quality of Life and the Influence of Stress on the Postoperative Course of Patients After Device Implantation

The project "Investigating Quality of Life and the Influence of Stress on the Postoperative Course of Patients After Device Implantation" aims to investigate the relationship between stress and the postoperative healing process of patients who have had a medical device implanted. These devices include pacemakers for the treatment of bradycardia, implantable cardioverter-defibrillators (ICDs) for the treatment of tachycardia in primary and secondary prevention, and cardiac resynchronization therapy (CRT) devices and event recorders. The study will analyze the influence of stress on the postoperative course, potential complications, and overall quality of life. A combination of medical examinations and surveys will be used to analyze how psychological stress influences the physical healing process and which measures can contribute to improving quality of life and treatment success. The surgical procedure for implanting devices is not part of the study; this is an observational study.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patients of legal capacity with an indication for device implantation (pacemaker, ICD, CRT, event recorder) who present at the Department of Cardiology and Angiology at the University Hospital Essen and consent to participate in the study will be included.

Exclusion criteria

  • none

Treatment and study plan

Survey using a questionnaire.

Other

survery over 36 months with comparison of the questionnares with risk-factors, blood-samples and physical fitness of the patient

Primary outcomes

  1. Cumulative incidence of device-related complications

    Time frame: 36 Months

    Measures the incidence of device-related complications, this includes: Complications related to Device- pockets, leads and infections connected to the devices

Secondary outcomes

  1. hospitalisation rate

    Time frame: 36 Months

    Analyzes how often and when the Patient got hospitalized

  2. Number of participants with the following arrhythmic events: ventrikular tachykardia and ventrikular fibrillation

    Time frame: Baseline, after 4-6 weeks, after 6 months, after 12 months, after 18 months, after 24 months, after 30 months, after 36 months

    Following device implantation, subsequent follow-up evaluations include device interrogation to assess stored arrhythmic events. Specifically, the analysis focuses on the detection of ventricular tachycardia and ventricular fibrillation. The frequency of these arrhythmias is systematically recorded for each study participant.

  3. Changes in functional capacity

    Time frame: Baseline (at 4-6 weeks) , after 6 months, after 12 months, after 18 months, after 24 months, after 30 months, after 36 months

    changes in functional capacity will be recorded using the established 6-minute walk test. The unit of measurement for the distance covered in 6 minutes will be meters.

  4. combined global stress measure

    Time frame: Baseline, after 4-6 weeks, after 6 months, after 12 months, after 18 months, after 24 months, after 30 months, after 36 months

    The outcome is based on a published RCT in Circulation by Blumenthal et al. . A global stress measure (mean rank), was the primary outcome combining the following components at baseline and following treatment: Beck Depression Inventory II, Spielberger Anxiety Inventory-State, General Health Questionnaire, PROMIS Anger Questionnaire, and Perceived Stress Scale. A range from 1 to 147 was present with higher scores suggestive of better function. The change in each individual scaled score is presented in secondary outcome. (see also NCT00981253)

  5. Health-related quality of life - SF-36

    Time frame: Baseline, after 4-6 weeks, after 6 months, after 12 months, after 18 months, after 24 months, after 30 months, after 36 months

    The investigators will apply the Short Form-36 health questionnaire [36,37]. The SF-36 is an eight-dimensional scale consisting of 36 items. It assesses health-related quality of life based on physical, social, and psychological functioning, role behavior due to physical and psychological functional impairment, physical pain, general health perception, and vitality.

  6. Health-related Quality of life - EQ-5D-5L

    Time frame: Baseline, after 4-6 weeks, after 6 months, after 12 months, after 18 months, after 24 months, after 30 months, after 36 months

    The investigators will apply the European Quality of Life 5 Dimensions 5 Level survey (EQ-5D-5L) [36,37]. The EQ-5D-5L consists of five health-related dimensions that can be assessed at five levels.

  7. Health-related Quality of life - VAS for general health

    Time frame: Baseline, after 4-6 weeks, after 6 months, after 12 months, after 18 months, after 24 months, after 30 months, after 36 months

    The questionnaire contains a visual analog scale for assessing general health. It consists of a straight line from 0 to 100, with endpoints representing extreme values-such as "worst imaginable health" on one side and "best imaginable health" on the other. The participants mark a position on the line. The position of the mark provides a numerical value.

  8. Depression symptoms (BDI-II)

    Time frame: Baseline, after 4-6 weeks, after 6 months, after 12 months, after 18 months, after 24 months, after 30 months, after 36 months

    The BDI-II is a self-report questionnaire comprising 21 items that assess depression severity. Its reliability and validity have been established through various studies among diverse populations and cultural backgrounds. Higher scores indicates increased depression symptoms

  9. Anxiety symptoms (STAI)

    Time frame: Baseline, after 4-6 weeks, after 6 months, after 12 months, after 18 months, after 24 months, after 30 months, after 36 months

    The STAI is the most authoritative tool for assessing anxiety in adults, precisely distinguishing between transient "state anxiety" and persistent "trait anxiety". The STAI measures anxiety with 20 items and has a range of 20 to 80. A higher score indicates more pronounced anxiety

  10. PROMIS-Anger Scale

    Time frame: Baseline, after 4-6 weeks, after 6 months, after 12 months, after 18 months, after 24 months, after 30 months, after 36 months

    The PROMIS Anger scale comprises eight items that evaluate various aspects of anger. Scores on the scale range from 8 to 40, with higher scores indicating greater levels of anger

  11. GHQ, Evaluation of distress

    Time frame: Baseline, after 4-6 weeks, after 6 months, after 12 months, after 18 months, after 24 months, after 30 months, after 36 months

    The GHQ assesses general distress and consists of 12 items. Respondents' scores range from 0 to 36, where higher scores correspond to increased distress

  12. Perceived Stress Scale

    Time frame: Baseline, after 4-6 weeks, after 6 months, after 12 months, after 18 months, after 24 months, after 30 months, after 36 months

    The Perceived Stress Scale-10 item version is a short tool for the assessment of how individuals perceive stress in their lives. The values range from 0 to 40. Higher values indicate higher perceived stress.

  13. Appropriate vs. inappropriate Shocks

    Time frame: Baseline, after 4-6 weeks, after 6 months, after 12 months, after 18 months, after 24 months, after 30 months, after 36 months

    All ICD shock events occurring during the follow-up period will be classified as either appropriate or inappropriate, based on predefined criteria.

    Appropriate shocks will be defined as those delivered in response to documented, life-threatening ventricular arrhythmias, including:

    • Ventricular tachycardia (VT)
    • Ventricular fibrillation (VF),

    Inappropriate shocks will be defined as those delivered in the absence of a qualifying ventricular arrhythmia. For example:

    -Supraventricular tachycardias (e.g., atrial fibrillation or flutter) misclassified as VT/VF or Oversensing due to lead malfunction, signal noise, or double counting.

    All shock events will be reviewed using intracardiac electrograms and device event logs retrieved from the ICD or CRT-D memory. When available, surface ECG data will be used to support rhythm interpretation.

    A shock will only be classified as appropriate if there is clear evidence of a ventricular arrythmia

  14. proinflammatory mediators- IL6

    Time frame: Baseline, after 4-6 weeks, after 6 months, after 12 months, after 18 months, after 24 months, after 30 months, after 36 months

    IL-6 is measured in pg/ml. Standard value is under 4.4 pg/ml. Higher values indicate an increased stress level

  15. Proinflammatory mediators - CRP

    Time frame: Baseline, after 4-6 weeks, after 6 months, after 12 months, after 18 months, after 24 months, after 30 months, after 36 months

    C-reactive protein (CRP) is measured in mg/dl. Standard value is under 0.5 mg/dl. Higher values indicate an increased stress level.

  16. Proinflammatory mediators- PCT

    Time frame: Baseline, after 4-6 weeks, after 6 months, after 12 months, after 18 months, after 24 months, after 30 months, after 36 months

    Procalcitonin is measured in ng/ml. Standard value is under 0.5 ng/ml. Higher values correlate with systemic inflammatory reaction and indicate bacterial infections.

Study contacts

Contact information is provided by the study sponsor or research team.

Julia Lortz, Prof. Dr. med.

CONTACT

[email protected]

+49 201-723 84995

Muhammed Kurt, Dr. med.

CONTACT

[email protected]

+49 201-723 86255

Sponsors and collaborators

Lead sponsor

University Hospital, Essen

Other

Registry information

Official study title

Klinische Studie Zur Untersuchung Der Lebensqualität Und Des Einflusses Von Stress Auf Den Postoperativen Verlauf Von Patienten Nach Device-Implantation

Important dates

Study start
2025
Primary completion
2029
Study completion
2029
First posted
Jan 15, 2026
Registry last updated
Jan 15, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.